Summary
The Serenity Foundation's efforts to subsidize ketamine therapy for low-income patients have significant implications for the future of mental health treatment. As **Dr. Bal Nandra**, founder and medical director of the IV Solution and Ketamine Centers of Chicago, notes, the foundation was started to help people who cannot afford ketamine treatment. With the help of organizations like the Serenity Foundation, patients can access life-changing treatments like ketamine infusion therapy, which has been shown to have a significant impact on patients with treatment-resistant depression, such as [[jason-prinzo|Jason Prinzo]] and [[brandon-lutts|Brandon Lutts]]. For more information on mental health advocacy and treatment options, visit [[mental-health-advocacy|mental health advocacy]] and [[depression-treatment|depression treatment]] pages.
Key Takeaways
- The Serenity Foundation provides need-based financial assistance to patients who cannot afford ketamine treatment
- Ketamine infusion therapy has a success rate of 60-70% in patients with major depressive disorder
- The lack of insurance coverage and high out-of-pocket costs make ketamine infusion therapy inaccessible to many
- The Serenity Foundation has funded nearly 3,000 infusion sessions and raised around $800,000
- More comprehensive solutions are needed to address the systemic issues that make ketamine infusion therapy unaffordable
Balanced Perspective
The Serenity Foundation's efforts to provide need-based financial assistance to patients who cannot afford ketamine treatment are a **step in the right direction**. However, more needs to be done to address the systemic issues that make ketamine infusion therapy inaccessible to many. The lack of insurance coverage and high out-of-pocket costs are significant barriers to access, and it will take a concerted effort from healthcare providers, insurers, and policymakers to make this treatment more widely available. As noted by [[dr-bal-nandra|Dr. Bal Nandra]], the founder and medical director of the IV Solution and Ketamine Centers of Chicago, the foundation was started to help people who cannot afford ketamine treatment, but more work is needed to address the underlying issues, as discussed in [[ketamine-therapy|ketamine therapy]] and [[healthcare-policy|healthcare policy]] pages.
Optimistic View
The Serenity Foundation's efforts to expand access to ketamine infusion therapy are a **game-changer** for patients with treatment-resistant depression. With a success rate of **60-70%**, ketamine infusion therapy has the potential to revolutionize the treatment of depression, especially for those who have tried other treatments without success. As noted by [[jason-prinzo|Jason Prinzo]], **ketamine saved his life**, and with the help of organizations like the Serenity Foundation, more patients can access this life-changing treatment. The foundation's work is a testament to the power of **innovative mental health treatments** and the importance of making them accessible to those who need them, as highlighted by [[ketamine-therapy|ketamine therapy]] and [[mental-health-advocacy|mental health advocacy]] organizations.
Critical View
Despite the promising results of ketamine infusion therapy, the lack of insurance coverage and high out-of-pocket costs make it **inaccessible to many**. The Serenity Foundation's efforts to provide need-based financial assistance are a **drop in the bucket** compared to the scale of the problem. Until there is a more comprehensive solution to address the systemic issues that make ketamine infusion therapy unaffordable, many patients will continue to suffer from treatment-resistant depression without access to this potentially life-changing treatment. As noted by [[jason-prinzo|Jason Prinzo]], **ketamine saved his life**, but many others are not as fortunate, highlighting the need for more affordable and equitable access to innovative mental health treatments, as discussed in [[mental-health-advocacy|mental health advocacy]] and [[depression-treatment|depression treatment]] pages.
Source
Originally reported by National Today